Cite

    Cristina Papayannidis et al.. “Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.” Hematological oncology, vol. 39, no. 4, 2021, pp. 580–583. http://access.bl.uk/ark:/81055/vdc_100144251470.0x000034